Filing Details
- Accession Number:
- 0000950170-24-094967
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-09 19:27:21
- Reporting Period:
- 2024-08-09
- Accepted Time:
- 2024-08-09 19:27:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1579428 | Axsome Therapeutics Inc. | AXSM | Pharmaceutical Preparations (2834) | 454241907 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1805812 | L. Mark Jacobson | C/O Axsome Therapeutics, Inc. One World Trade Center, 22Nd Floor New York NY 10007 | Chief Operating Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-08-09 | 47,739 | $4.04 | 53,522 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-08-09 | 47,739 | $84.26 | 5,783 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-08-09 | 47,739 | $0.00 | 47,739 | $4.04 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-12-29 | 2024-12-29 | No | 4 | M | Direct |
Footnotes
- Represents an exercise of stock options prior to the 10-year expiration date of such options, which would occur later this year.
- Such transaction was pursuant to a pre-approved 10b5-1 plan.
- Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options.
- Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $82.705 and $85.975.
Billionaire Hedge Funds
